Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Glibenclamide manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

5 products found

glibenclamide + metformin

Tablets 2.5mg + 500mg, 5mg + 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16388
It develops quality products that remain in force to this day. The primary objective is to allow greater efficiency in medical work, allowing professionals to keep pace with the progress of biochemical and bacteriological methods in the world, for the best diagnosis of diseases. Over time, it has become one of the pharmaceutical companies with more than 100 years of experience in the national market. With high-quality and renowned products.

Manufacturer usually replies in 4 days

glibenclamide

Tablets 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
COFEPRIS, INVIMA
Manufacturer #2261

The company researches to develop and provide top-quality products and technological development to improve health and quality of life. The company has been committed for more than 100 years and they are constantly evolving with the ever-changing market and staying in forefront of modern pharmacopeia.

Manufacturer usually replies in 6 days

glibenclamide

Tablets 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #16332
With more than a half-century of expertise, the company has established itself as a market leader in the production of generic pharmaceuticals. The items are sold on the domestic market and in countries such as Bolivia, Chile, Uruguay, Paraguay, Ecuador, Colombia, Azerbaijan, and Yemen. With a track record that includes antimicrobials, anti-inflammatories, analgesics, antihypertensives, and anti ulcerative, among many others, the company is now known as the laboratory with the largest medication reference guide on the market.

Manufacturer usually replies in 19 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Glibenclamide:

Glibenclamide, or also known as glyburide, is a drug used for the effective treatment of type 2 diabetes. It was developed in the 1960s during a cooperative study between the two companies Boehringer Mannheim (now Roche) and Hoechst (now Sanofi-Aventis). Following appraisal, it was approved for medical use in the United States in 1984. Glibenclamide can now be distributed in a cost effective manner as a generic medication in line with other pharmaceutical products which have had their patent expire. As such, it is offered for both sale and wholesale at various price points and under different brand names, including Gliben-J, Daonil, Diabeta, Euglucon, Gilemal, Glidanil, Glybovin, Glynase, Maninil, Micronase and Semi-Daonil. Additionally, glibenclamide manufacturers commonly list it as a combination drug with metformin. Which is sold under brand names, including Bagomet Plus, Benimet, Glibomet, Gluconorm, Glucored, Glucovance, Metglib, and others.

Method of action of glibenclamide:

Glibenclamide belongs to a group of drugs called sulfonylureas which treat type 2 diabetes by augmenting the secretion of insulin in pancreatic beta cells. This is facilitated by the inhibition of regulatory subunits causing cell membrane depolarization, allowing calcium access intracellularly and subsequent stimulation of insulin release. With insulin being the hormone responsible for the regulation of blood sugar by promoting the absorption of glucose from the blood into the liver, fat, and skeletal muscle cells. Conferring effective treatment of type 2 diabetes and associated symptoms such as excessive thirst, dysuria, and lethargies.

Glibenclamide containment and dosage:

Glibenclamide manufacturers and glibenclamide suppliers package the medication in tablet, capsule, or oral suspension form. With one 5mg tablet or capsule typically being prescribed to be taken once a day with breakfast or immediately after. This dose can be adjusted by a medical professional up to a recommended two 15mg doses twice a day. It is best taken alongside participation in exercise and at a consistent time. Liquid suspensions are predominantly used for the treatment of infants, with the dosage adjusted to match.

Glibenclamide on Pipelinepharma:

Due to the generic nature, there exists a wide variety of glibenclamide suppliers, distributors, and manufacturers on the market offering their product for wholesale. Searching on our company Pipelinepharma.com online marketplace currently reveals 28 verified global B2B providers located in countries, including India, Mexico, Turkey, the European Union, Israel, Ukraine, Brazil, Switzerland, Jordan, China, South Korea, Egypt, Argentina, Russian, Kuwait, and Oman. These are trusted manufacturers and distributors which have been verified according to strict quality control by the Pipelinepharma team.

Price of glibenclamide and how to buy:

As with other products, the cost of purchase remains confidential and negotiable online between both B2B parties. However, in certain cases, the manufacturer or wholesaler may have chosen to include a desired price to facilitate an order, if so, this indicated cost per sample will be visible in the Pipelinepharma.com list. As such, this enables a clear route for a buyer looking to source glibenclamide or any other pharmaceutical products from an array of global trusted manufacturers and distributors.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation